JPRN-UMIN000002593已完成未知
Recognized Effect of Statin and Ezetimibe therapy for achievement LDL-C Goal - RESEARCH
Clinical study group for diabetes and dyslipidemia0 个研究点目标入组 120 人开始时间: 2009年10月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) History of hypersensitivity to atorvastatin, pitavastatin or ezetimibe (2) Serum triglyceride level more than 400mg/dl (3) Hepatic dysfunction (an alanine aminotransferase level that is more than twice the upper limit of the normal range) (4) Uncontrolled diabetes (HbA1c more than 9.0%) (5) Renal dysfunction (a creatinine level that is higher than 2.0 mg per deciliter) (6) Secondary or drug-induced hypercholesterolemia (7) Homozygous familial hypercholesterolemia (8) Pregnant or nursing women or women suspect of pregnancy (9) Judged as inappropriate for study by doctor
研究者
相似试验
已完成
不适用
therapeutic efficacy of ezetimibe and statins for vascular endothelial dysfunction by high-fat diet loadingin patients with type 2 diabetesType 2 diabetes HyperlipidemiaJPRN-UMIN000018629niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine20
进行中（未招募）
不适用
Effects of ezetimibe in association with statins on postprandial lipemia in type 2 diabetic patients - Ezetimibe effects on postprandial lipemiaEUCTR2008-000824-20-ITIVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II
未知
4 期
Effect of ezetimibe/statin combination therapy in patients with type 2 diabetes and dyslipidemia on remnant and inflammatioJPRN-UMIN000002318Kobe University Graduate School of Medicine, Division of Diabetes, Metabolism and Endocrinology100
已完成
不适用
Effect of statin with ezetimibe versus statin alone on progression of coronary atherosclerotic plaque: Evaluate by Intravasclular ultrasound Virtual Histology and Optical Coherence TomographyIschemic heart diseaseJPRN-UMIN000005563Toyohashi Heart Ceter, Cardiovascular Medicine100
已完成
不适用
The impact of additive EPA or ezetimibe to statin therapy on the stabilization of vulnerable plaque; Assessment by OCTIschemic heart diseaseJPRN-UMIN000011934Kobe University Graduate School of Medicine80